| Wuca - Women's Care Specialists | |
|
209 First Executive Ave Saint Peters MO 63376-1697 | |
| (636) 936-8777 | |
| Not Available |
| Full Name | Wuca - Women's Care Specialists |
|---|---|
| Speciality | Clinic/Center |
| Location | 209 First Executive Ave, Saint Peters, Missouri |
| Authorized Official Name and Position | Cathy Eghigian (SR. DIRECTOR, WU MANAGED CARE) |
| Authorized Official Contact | 6187910975 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Wuca - Women's Care Specialists 209 First Executive Ave Saint Peters MO 63376-1697 Ph: (636) 936-8777 | Wuca - Women's Care Specialists 209 First Executive Ave Saint Peters MO 63376-1697 Ph: (636) 936-8777 |
| NPI Number | 1609582964 |
|---|---|
| Provider Enumeration Date | 01/30/2023 |
| Last Update Date | 02/08/2024 |
| Medicare PECOS PAC ID | 9830008770 |
|---|---|
| Medicare Enrollment ID | O20230425002338 |
News Archive
The University of Michigan's second human embryonic stem cell line has just been placed on the U.S. National Institutes of Health's registry, making the cells available for federally-funded research. It is the second of the stem cell lines derived at U-M to be placed on the registry.
NewLink Genetics Corporation today announced positive Phase 2 clinical trial data of its HyperAcute®-Pancreas cancer immunotherapy combined with standard adjuvant chemotherapy in patients with surgically resectable pancreatic cancer. The study results suggest a potentially longer disease-free survival and one-year overall survival in this patient group than reported in previous studies of surgery and adjuvant therapy alone. These data were presented in a poster session at the American Society of Clinical Oncology (ASCO) annual meeting.
Ultra-miniature bialy-shaped particles - called nanobialys because they resemble tiny versions of the flat, onion-topped rolls popular in New York City - could soon be carrying medicinal compounds through patients' bloodstreams to tumors or atherosclerotic plaques.
Neutron scattering research at the Department of Energy's Oak Ridge National Laboratory has revealed clear structural differences in the normal and pathological forms of a protein involved in Huntington's disease.
The Hill's Healthwatch Blog: The House Wednesday passed a bill that would ban executives from "doing business with Medicare if their companies were convicted of fraud, even if the conviction takes place after their departure. The bill was introduced by the Ways and Means health panel's chairman and ranking member, Reps. Pete Stark (D-Calif.) and Wally Herger (R-Calif.)."
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609582964 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QM1300X | Clinic/center - Multi-specialty | (* (Not Available)) | Primary |
| Provider Name | Janet Matuszek |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1265542146 PECOS PAC ID: 2860582962 Enrollment ID: I20071213000047 |
News Archive
The University of Michigan's second human embryonic stem cell line has just been placed on the U.S. National Institutes of Health's registry, making the cells available for federally-funded research. It is the second of the stem cell lines derived at U-M to be placed on the registry.
NewLink Genetics Corporation today announced positive Phase 2 clinical trial data of its HyperAcute®-Pancreas cancer immunotherapy combined with standard adjuvant chemotherapy in patients with surgically resectable pancreatic cancer. The study results suggest a potentially longer disease-free survival and one-year overall survival in this patient group than reported in previous studies of surgery and adjuvant therapy alone. These data were presented in a poster session at the American Society of Clinical Oncology (ASCO) annual meeting.
Ultra-miniature bialy-shaped particles - called nanobialys because they resemble tiny versions of the flat, onion-topped rolls popular in New York City - could soon be carrying medicinal compounds through patients' bloodstreams to tumors or atherosclerotic plaques.
Neutron scattering research at the Department of Energy's Oak Ridge National Laboratory has revealed clear structural differences in the normal and pathological forms of a protein involved in Huntington's disease.
The Hill's Healthwatch Blog: The House Wednesday passed a bill that would ban executives from "doing business with Medicare if their companies were convicted of fraud, even if the conviction takes place after their departure. The bill was introduced by the Ways and Means health panel's chairman and ranking member, Reps. Pete Stark (D-Calif.) and Wally Herger (R-Calif.)."
› Verified 6 days ago
| Provider Name | Megan M Mohrman |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1225472178 PECOS PAC ID: 8426321571 Enrollment ID: I20170912001125 |
News Archive
The University of Michigan's second human embryonic stem cell line has just been placed on the U.S. National Institutes of Health's registry, making the cells available for federally-funded research. It is the second of the stem cell lines derived at U-M to be placed on the registry.
NewLink Genetics Corporation today announced positive Phase 2 clinical trial data of its HyperAcute®-Pancreas cancer immunotherapy combined with standard adjuvant chemotherapy in patients with surgically resectable pancreatic cancer. The study results suggest a potentially longer disease-free survival and one-year overall survival in this patient group than reported in previous studies of surgery and adjuvant therapy alone. These data were presented in a poster session at the American Society of Clinical Oncology (ASCO) annual meeting.
Ultra-miniature bialy-shaped particles - called nanobialys because they resemble tiny versions of the flat, onion-topped rolls popular in New York City - could soon be carrying medicinal compounds through patients' bloodstreams to tumors or atherosclerotic plaques.
Neutron scattering research at the Department of Energy's Oak Ridge National Laboratory has revealed clear structural differences in the normal and pathological forms of a protein involved in Huntington's disease.
The Hill's Healthwatch Blog: The House Wednesday passed a bill that would ban executives from "doing business with Medicare if their companies were convicted of fraud, even if the conviction takes place after their departure. The bill was introduced by the Ways and Means health panel's chairman and ranking member, Reps. Pete Stark (D-Calif.) and Wally Herger (R-Calif.)."
› Verified 6 days ago
| Provider Name | Angela Marie Warner |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1477077394 PECOS PAC ID: 5496110462 Enrollment ID: I20230426000916 |
News Archive
The University of Michigan's second human embryonic stem cell line has just been placed on the U.S. National Institutes of Health's registry, making the cells available for federally-funded research. It is the second of the stem cell lines derived at U-M to be placed on the registry.
NewLink Genetics Corporation today announced positive Phase 2 clinical trial data of its HyperAcute®-Pancreas cancer immunotherapy combined with standard adjuvant chemotherapy in patients with surgically resectable pancreatic cancer. The study results suggest a potentially longer disease-free survival and one-year overall survival in this patient group than reported in previous studies of surgery and adjuvant therapy alone. These data were presented in a poster session at the American Society of Clinical Oncology (ASCO) annual meeting.
Ultra-miniature bialy-shaped particles - called nanobialys because they resemble tiny versions of the flat, onion-topped rolls popular in New York City - could soon be carrying medicinal compounds through patients' bloodstreams to tumors or atherosclerotic plaques.
Neutron scattering research at the Department of Energy's Oak Ridge National Laboratory has revealed clear structural differences in the normal and pathological forms of a protein involved in Huntington's disease.
The Hill's Healthwatch Blog: The House Wednesday passed a bill that would ban executives from "doing business with Medicare if their companies were convicted of fraud, even if the conviction takes place after their departure. The bill was introduced by the Ways and Means health panel's chairman and ranking member, Reps. Pete Stark (D-Calif.) and Wally Herger (R-Calif.)."
› Verified 6 days ago
| Provider Name | Julie E Schweitzer |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1215479134 PECOS PAC ID: 2961869235 Enrollment ID: I20230531002554 |
News Archive
The University of Michigan's second human embryonic stem cell line has just been placed on the U.S. National Institutes of Health's registry, making the cells available for federally-funded research. It is the second of the stem cell lines derived at U-M to be placed on the registry.
NewLink Genetics Corporation today announced positive Phase 2 clinical trial data of its HyperAcute®-Pancreas cancer immunotherapy combined with standard adjuvant chemotherapy in patients with surgically resectable pancreatic cancer. The study results suggest a potentially longer disease-free survival and one-year overall survival in this patient group than reported in previous studies of surgery and adjuvant therapy alone. These data were presented in a poster session at the American Society of Clinical Oncology (ASCO) annual meeting.
Ultra-miniature bialy-shaped particles - called nanobialys because they resemble tiny versions of the flat, onion-topped rolls popular in New York City - could soon be carrying medicinal compounds through patients' bloodstreams to tumors or atherosclerotic plaques.
Neutron scattering research at the Department of Energy's Oak Ridge National Laboratory has revealed clear structural differences in the normal and pathological forms of a protein involved in Huntington's disease.
The Hill's Healthwatch Blog: The House Wednesday passed a bill that would ban executives from "doing business with Medicare if their companies were convicted of fraud, even if the conviction takes place after their departure. The bill was introduced by the Ways and Means health panel's chairman and ranking member, Reps. Pete Stark (D-Calif.) and Wally Herger (R-Calif.)."
› Verified 6 days ago
| Provider Name | Marcy Elizabeth Haley |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1912274341 PECOS PAC ID: 5193155752 Enrollment ID: I20230601001596 |
News Archive
The University of Michigan's second human embryonic stem cell line has just been placed on the U.S. National Institutes of Health's registry, making the cells available for federally-funded research. It is the second of the stem cell lines derived at U-M to be placed on the registry.
NewLink Genetics Corporation today announced positive Phase 2 clinical trial data of its HyperAcute®-Pancreas cancer immunotherapy combined with standard adjuvant chemotherapy in patients with surgically resectable pancreatic cancer. The study results suggest a potentially longer disease-free survival and one-year overall survival in this patient group than reported in previous studies of surgery and adjuvant therapy alone. These data were presented in a poster session at the American Society of Clinical Oncology (ASCO) annual meeting.
Ultra-miniature bialy-shaped particles - called nanobialys because they resemble tiny versions of the flat, onion-topped rolls popular in New York City - could soon be carrying medicinal compounds through patients' bloodstreams to tumors or atherosclerotic plaques.
Neutron scattering research at the Department of Energy's Oak Ridge National Laboratory has revealed clear structural differences in the normal and pathological forms of a protein involved in Huntington's disease.
The Hill's Healthwatch Blog: The House Wednesday passed a bill that would ban executives from "doing business with Medicare if their companies were convicted of fraud, even if the conviction takes place after their departure. The bill was introduced by the Ways and Means health panel's chairman and ranking member, Reps. Pete Stark (D-Calif.) and Wally Herger (R-Calif.)."
› Verified 6 days ago
News Archive
The University of Michigan's second human embryonic stem cell line has just been placed on the U.S. National Institutes of Health's registry, making the cells available for federally-funded research. It is the second of the stem cell lines derived at U-M to be placed on the registry.
NewLink Genetics Corporation today announced positive Phase 2 clinical trial data of its HyperAcute®-Pancreas cancer immunotherapy combined with standard adjuvant chemotherapy in patients with surgically resectable pancreatic cancer. The study results suggest a potentially longer disease-free survival and one-year overall survival in this patient group than reported in previous studies of surgery and adjuvant therapy alone. These data were presented in a poster session at the American Society of Clinical Oncology (ASCO) annual meeting.
Ultra-miniature bialy-shaped particles - called nanobialys because they resemble tiny versions of the flat, onion-topped rolls popular in New York City - could soon be carrying medicinal compounds through patients' bloodstreams to tumors or atherosclerotic plaques.
Neutron scattering research at the Department of Energy's Oak Ridge National Laboratory has revealed clear structural differences in the normal and pathological forms of a protein involved in Huntington's disease.
The Hill's Healthwatch Blog: The House Wednesday passed a bill that would ban executives from "doing business with Medicare if their companies were convicted of fraud, even if the conviction takes place after their departure. The bill was introduced by the Ways and Means health panel's chairman and ranking member, Reps. Pete Stark (D-Calif.) and Wally Herger (R-Calif.)."
› Verified 6 days ago
Medical Essentials Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2730 S Saint Peters Pkwy, Suite 203, Saint Peters, MO 63303 Phone: 314-414-0700 | |
Family Medical Group Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 514 Jungermann Rd, Saint Peters, MO 63376 Phone: 636-441-3322 Fax: 636-441-4302 | |
Lawrence S Tierney Md Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 6 Jungermann Circle, Suite 103, Saint Peters, MO 63376 Phone: 636-928-0022 Fax: 636-928-0023 | |
Practice Management Affiliates Consulting Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1600 Heritage Lndg, Suite 215, Saint Peters, MO 63303 Phone: 636-939-4200 Fax: 636-939-4204 | |
Compass Health, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 8075 Mexico Rd, Saint Peters, MO 63376 Phone: 573-234-5258 | |
Morningstar Neuropathy & Pain Treatment Center Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 4710 Mexico Rd, Saint Peters, MO 63376 Phone: 636-244-0124 Fax: 618-876-7850 | |
Careatc-saint Peter Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4601 Executive Centre Pkwy, Saint Peters, MO 63376 Phone: 918-779-7416 |